Published in J Virol on November 21, 2007
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
Proteomics of the Autographa californica nucleopolyhedrovirus budded virions. J Virol (2010) 1.44
Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine (2012) 1.27
Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J Virol (2010) 1.10
Chromatin organization and virus gene expression. J Cell Physiol (2008) 1.08
Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog (2011) 1.05
Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology (2012) 1.04
Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity. J Proteome Res (2011) 0.91
Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J Virol (2013) 0.86
Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach. Virol J (2009) 0.86
Proteomic analysis of purified coronavirus infectious bronchitis virus particles. Proteome Sci (2010) 0.82
Cellular proteins associated with the interior and exterior of vesicular stomatitis virus virions. PLoS One (2014) 0.78
Maturation of the Gag core decreases the stability of retroviral lipid membranes. Virology (2012) 0.77
Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue. BMC Infect Dis (2015) 0.76
Gene duplication and phylogeography of North American members of the Hart Park serogroup of avian rhabdoviruses. Virology (2013) 0.76
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens. Sci Rep (2016) 0.75
Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs. BMC Proc (2011) 0.75
P64, a novel major virion DNA-binding protein potentially involved in condensing the Spodoptera frugiperda Ascovirus 1a genome. J Virol (2009) 0.75
hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles. Sci Rep (2016) 0.75
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A (2004) 8.74
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell (2003) 6.69
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (2001) 6.32
Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem (1998) 5.79
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A (1984) 5.13
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol (1999) 4.87
Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol (2003) 4.68
Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic (2003) 4.61
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem (2003) 4.14
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol (2006) 3.59
Tetraspanins. Cell Mol Life Sci (2001) 3.33
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24
Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem (2003) 2.97
Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med (1996) 2.73
Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol (1996) 2.65
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol (1997) 2.54
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics (2004) 2.43
Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J Cell Biol (2006) 2.38
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol (1994) 2.36
Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses (1993) 2.36
Ubiquitination of HIV-1 and MuLV Gag. Virology (2000) 2.33
Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology (1997) 2.30
Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev Cell (2003) 2.22
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol (1999) 2.15
Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol (2004) 2.13
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01
Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol (2005) 1.98
Cellular proteins in HIV virions. Rev Med Virol (1997) 1.90
Endosomes, exosomes and Trojan viruses. Trends Microbiol (2004) 1.84
Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J (2004) 1.77
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem (2001) 1.74
EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem (2001) 1.72
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol (1995) 1.63
Integrin, a transmembrane glycoprotein complex mediating cell-substratum adhesion. J Cell Sci Suppl (1987) 1.62
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J Virol (1997) 1.59
Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol Reprod (2005) 1.51
Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol (2002) 1.50
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J (2003) 1.50
Potential roles of cellular proteins in HIV-1. Rev Med Virol (2002) 1.48
T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol (1998) 1.48
Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol (2006) 1.48
Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature (1996) 1.46
Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem (2002) 1.38
Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur J Biochem (2000) 1.35
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol (1998) 1.18
Rapid virus subunit visualization by direct sedimentation of samples on electron microscope grids. J Virol Methods (1987) 1.17
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther (2001) 1.16
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol (2006) 1.15
Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production. J Biol (2003) 1.14
Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res Hum Retroviruses (2000) 1.12
Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res (2006) 1.08
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. J Virol (2002) 0.97
Antibody-mediated targeting of replication-competent retroviral vectors. Hum Gene Ther (2003) 0.95
Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum Gene Ther (2001) 0.92
Identification of CD9 extracellular domains important in regulation of CHO cell adhesion to fibronectin and fibronectin pericellular matrix assembly. Blood (2002) 0.92
Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. Virology (1999) 0.89
Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein. EMBO Rep (2002) 0.89
A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng (2005) 0.88
Chinese hamster ovary cell motility to fibronectin is modulated by the second extracellular loop of CD9. Identification of a putative fibronectin binding site. J Biol Chem (2002) 0.83
Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. J Virol Methods (2005) 0.83
Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells. Hum Gene Ther (2001) 0.82
Elimination of redundant protein identifications in high throughput proteomics. Conf Proc IEEE Eng Med Biol Soc (2005) 0.81
Retroviral gene transfer to human epidermal keratinocytes correlates with integrin expression and is significantly enhanced on fibronectin. Hum Gene Ther (2002) 0.78
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res (2002) 6.64
EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet (2007) 2.33
Specific GATA factors act as conserved inducers of an endodermal-EMT. Dev Cell (2011) 1.64
Polyploid megakaryocytes can complete cytokinesis. Cell Cycle (2010) 1.57
Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol Bioeng (2003) 1.18
Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol (2008) 1.08
Characterization of yeastolate fractions that promote insect cell growth and recombinant protein production. Cytotechnology (2007) 1.06
Improving glucose and glutamine metabolism of human HEK 293 and Trichoplusia ni insect cells engineered to express a cytosolic pyruvate carboxylase enzyme. Biotechnol Prog (2003) 1.04
Production of adenovirus vector for gene therapy. Biotechnol Adv (2003) 1.03
Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol Prog (2005) 1.03
Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng (2007) 1.02
Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol (2006) 0.99
Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. J Virol Methods (2007) 0.99
Quantitation of baculovirus particles by flow cytometry. J Virol Methods (2002) 0.98
High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog (2004) 0.97
Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme. Protein Expr Purif (2005) 0.96
Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng (2004) 0.94
Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol Prog (2006) 0.93
Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII. BMC Biotechnol (2011) 0.92
A survey of the methods for the characterization of microbial consortia and communities. Can J Microbiol (2005) 0.92
Effect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystals. ACS Appl Mater Interfaces (2010) 0.92
Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol Adv (2006) 0.91
Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol (2005) 0.91
Selection and tuning of a fast and simple phase-contrast microscopy image segmentation algorithm for measuring myoblast growth kinetics in an automated manner. Microsc Microanal (2013) 0.91
Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media. Hum Gene Ther (2009) 0.90
Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. FEMS Microbiol Lett (2007) 0.89
Megakaryocyte and platelet production from human cord blood stem cells. Methods Mol Biol (2012) 0.89
Overview of current scalable methods for purification of viral vectors. Methods Mol Biol (2011) 0.88
A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng (2005) 0.88
Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J Virol Methods (2006) 0.88
High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnol Bioeng (2010) 0.87
Insights into the central metabolism of Spodoptera frugiperda (Sf-9) and Trichoplusia ni BTI-Tn-5B1-4 (Tn-5) insect cells by radiolabeling studies. Biotechnol Prog (2005) 0.87
Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures. Biotechnol Bioeng (2004) 0.87
Single-cell level analysis of megakaryocyte growth and development. Differentiation (2012) 0.86
Analysis of baculovirus aggregates using flow cytometry. J Virol Methods (2005) 0.86
Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. J Gene Med (2009) 0.86
New developments in lentiviral vector design, production and purification. Expert Opin Biol Ther (2013) 0.86
High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnol Prog (2007) 0.85
Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. Cytotherapy (2010) 0.85
Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum Gene Ther (2003) 0.85
Production and formulation of adenovirus vectors. Adv Biochem Eng Biotechnol (2005) 0.84
New protocol for lentiviral vector mass production. Methods Mol Biol (2010) 0.84
Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess Biosyst Eng (2010) 0.83
Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. J Virol Methods (2005) 0.83
Probing inhibitory effects of Antrodia camphorata isolates using insect cell-based impedance spectroscopy: inhibition vs chemical structure. Chem Res Toxicol (2008) 0.82
Ex vivo megakaryocyte expansion and platelet production from human cord blood stem cells. Methods Mol Biol (2009) 0.82
Micro-quantitation of lipids in serum-free cell culture media: a critical aspect is the minimization of interference from medium components and chemical reagents. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.82
High yield purification of functional baculovirus vectors by size exclusion chromatography. J Virol Methods (2007) 0.82
Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnol Bioeng (2006) 0.81
Recombinant protein production in large-scale agitated bioreactors using the baculovirus expression vector system. Methods Mol Biol (2007) 0.81
Probing inhibitory effects of nanocrystalline cellulose: inhibition versus surface charge. Nanoscale (2012) 0.81
Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins. BMC Biotechnol (2009) 0.81
Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.80
An efficient process for the purification of helper-dependent adenoviral vector and removal of helper virus by iodixanol ultracentrifugation. J Virol Methods (2010) 0.80
Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3. J Pharm Biomed Anal (2007) 0.79
A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. Int J Nanomedicine (2012) 0.79
Cell culture tracking by multivariate analysis of raw LCMS data. Appl Biochem Biotechnol (2012) 0.78
Multivariate analysis of single quadrupole LC-MS spectra for routine characterization and quantification of intact proteins. Proteomics (2009) 0.77
Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures. Biotechnol Adv (2004) 0.77
Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures. Biotechnol Prog (2012) 0.77
Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions. J Virol Methods (2008) 0.76
Purification of retrovirus particles using heparin affinity chromatography. Methods Mol Biol (2008) 0.76
PH, pCO2, and temperature effect on R-adenovirus production. Biotechnol Prog (2003) 0.76
High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.76
A fluorophore-tagged RGD peptide to control endothelial cell adhesion to micropatterned surfaces. Biomaterials (2013) 0.76
Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3). Vaccine (2011) 0.76
Evaluation of homogeneity and genetic stability of REOLYSIN (pelareorep) by complete genome sequencing of reovirus after large scale production. Appl Microbiol Biotechnol (2014) 0.76
Rapid and reliable quantification of reovirus type 3 by high performance liquid chromatography during manufacturing of Reolysin. J Pharm Biomed Anal (2008) 0.76
On the proper use of statistical design of experiments. Exp Hematol (2005) 0.75
Reassessing culture media and critical metabolites that affect adenovirus production. Biotechnol Prog (2010) 0.75
Hyperosmotic pressure on HEK 293 cells during the growth phase, but not the production phase, improves adenovirus production. J Biotechnol (2011) 0.75
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus. Biotechnol Bioeng (2007) 0.75
Probing inhibitory effects of destruxins from Metarhizium anisopliae using insect cell based impedance spectroscopy: inhibition vs chemical structure. Analyst (2009) 0.75